Fei Ding
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
Papers in
-
- Gut microbiota and health 3
- Advanced biosensing and bioanalysis techniques 3
- Oncology 20
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Yan Lin (8 shared papers)John M. Kirkwood (6 shared papers)Cindy Sander (5 shared papers)Yue Yu (2 shared papers)Chao Xu (1 shared paper)Melissa Saul (2 shared papers)Yong He (7 shared papers)Ahmad A. Tarhini (5 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Frontiers in Pediatrics (5 papers)Journal for ImmunoTherapy of Cancer (3 papers)Frontiers in Immunology (3 papers)Frontiers in Public Health (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Fei Ding
76 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 124
- Oncology 312
- Immunology 236
- Cancer Research 131
- Molecular Biology 536
- Geriatrics and Gerontology 24
Countries citing papers authored by Fei Ding
This map shows the geographic impact of Fei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Ding more than expected).
Fields of papers citing papers by Fei Ding
This network shows the impact of papers produced by Fei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Ding. The network helps show where Fei Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 80 | |
| 2 | 2019 | 73 | |
| 3 | 2011 | 69 | |
| 4 | 2018 | 69 | |
| 5 | 2019 | 67 | |
| 6 | 2017 | 58 | |
| 7 | 2019 | 56 | |
| 8 | 2020 | 56 | |
| 9 | 2018 | 54 | |
| 10 | 2019 | 48 | |
| 11 | 2008 | 46 | |
| 12 | 2019 | 41 | |
| 13 | 2021 | 40 | |
| 14 | 2017 | 39 | |
| 15 | 2018 | 37 | |
| 16 | 2023 | 36 | |
| 17 | 2018 | 36 | |
| 18 | 2013 | 31 | |
| 19 | 2013 | 31 | |
| 20 | 2023 | 26 |
About Fei Ding
Fei Ding is a scholar working on Molecular Biology, Oncology, Immunology, Epidemiology and Rheumatology, having authored 83 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Gut microbiota and health (3 papers), Nutrition and Health in Aging (3 papers), Cell Adhesion Molecules Research (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Oncology (312 citations), Immunology (236 citations), Cancer Research (131 citations), Molecular Biology (536 citations) and Geriatrics and Gerontology (24 citations). Fei Ding has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yan Lin, John M. Kirkwood, Cindy Sander, Yue Yu, Chao Xu, Melissa Saul, Yong He, Ahmad A. Tarhini, Yushan Liu and Jing Yu. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Pediatrics, Journal for ImmunoTherapy of Cancer, Frontiers in Immunology and Frontiers in Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.